China Health Management Stock Price To Earning
| CNHC Stock | USD 0.01 0.00 0.00% |
China Health Management fundamentals help investors to digest information that contributes to China Health's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Health pink sheet.
China |
China Health Management Company Price To Earning Analysis
China Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current China Health Price To Earning | (1.80) X |
Most of China Health's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Health Management is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, China Health Management has a Price To Earning of -1.8 times. This is 109.85% lower than that of the Technology Hardware, Storage & Peripherals sector and significantly lower than that of the Information Technology industry. The price to earning for all United States stocks is 106.27% higher than that of the company.
China Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Health's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Health could also be used in its relative valuation, which is a method of valuing China Health by comparing valuation metrics of similar companies.China Health is currently under evaluation in price to earning category among related companies.
China Fundamentals
| Profit Margin | (0.24) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 17.53 M | |||
| Shares Outstanding | 81.15 M | |||
| Price To Earning | (1.80) X | |||
| Price To Sales | 3.18 X | |||
| Revenue | 542.38 K | |||
| Gross Profit | 108.47 K | |||
| Net Income | (129.28 K) | |||
| Current Ratio | 1.09 X | |||
| Book Value Per Share | 0 X | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 13 | |||
| Beta | 1.28 | |||
| Market Capitalization | 929.12 K | |||
| Total Asset | 5.2 M | |||
| Retained Earnings | (34.26 M) | |||
| Working Capital | 5.16 M | |||
| Current Asset | 9.37 M | |||
| Current Liabilities | 4.21 M | |||
| Z Score | -8.4 | |||
| Net Asset | 5.2 M |
About China Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Health Management's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Health Management based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Health's short interest history, or implied volatility extrapolated from China Health options trading.
Pair Trading with China Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Health will appreciate offsetting losses from the drop in the long position's value.Moving against China Pink Sheet
| 0.51 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.46 | BAC | Bank of America Sell-off Trend | PairCorr |
| 0.45 | XOM | Exxon Mobil Corp Financial Report 26th of July 2024 | PairCorr |
| 0.43 | LRDG | Lord Global Corp | PairCorr |
The ability to find closely correlated positions to China Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace China Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back China Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling China Health Management to buy it.
The correlation of China Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as China Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if China Health Management moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for China Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Health Management. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the China Health Management information on this page should be used as a complementary analysis to other China Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for China Pink Sheet analysis
When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |